Vivos Therapeutics Inc. (VVOS)

AI Score

Unlock

2.10

0.02 (0.96%)

At close: Apr 17, 2025, 3:58 PM

2.12

0.95%

After-hours: Apr 17, 2025, 07:23 PM EDT

Vivos Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Cash & Equivalents	6.26M	6.31M	6.9M	2.61M	1.64M	988K	3.94M	7.05M	3.52M	6.72M	12.66M	17.83M	24.03M	28.53M	34.2M	14.06M	18.21M	1.55M	413.62K	-469.35K	469.35K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	938.71K	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	842.29K	846.21K	816.58K	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	216K	276K	276K	308K	307K	307K	308K	308K	374K	372K	373K	354K	356K	1.2M	1.22M	1.19M	1.12M	1.11M	1.09M	-469.35K	1.07M
Receivables	430K	454K	395K	525K	202K	228K	327K	321K	457K	866K	791K	1.52M	1.72M	3.89M	3.52M	1.75M	1.43M	936.66K	586.99K	n/a	955.99K
Inventory	n/a	n/a	n/a	n/a	1.00	n/a	1.00	1.00	n/a	n/a	n/a	n/a	n/a	-61.86K	n/a	n/a	1.00	1.00	1.00	n/a	n/a
Other Current Assets	783K	634K	554K	475K	616K	769K	1.07M	1.35M	1.45M	2.12M	2.06M	n/a	n/a	n/a	1.67M	927.63K	84K	370.8K	316.05K	n/a	263.81K
Total Current Assets	7.47M	7.4M	7.85M	3.61M	2.46M	1.99M	5.34M	8.71M	5.42M	9.7M	15.51M	21.6M	27.32M	34.03M	39.39M	16.74M	20.39M	3.39M	1.65M	469.35K	1.98M
Property-Plant & Equipment	4.38M	4.45M	4.48M	4.63M	4.7M	4.75M	4.81M	4.78M	4.78M	5.17M	5.32M	4.43M	2.83M	2.6M	2.29M	1.06M	871.6K	938.24K	1M	n/a	1.14M
Goodwill & Intangibles	3.21M	3.23M	3.24M	3.25M	3.26M	3.28M	3.29M	3.3M	3.15M	3.15M	3.17M	3.17M	3.18M	3.19M	3.26M	2.97M	2.94M	3.05M	3.15M	n/a	3.36M
Total Long-Term Assets	7.81M	7.95M	7.99M	8.19M	8.27M	8.33M	8.41M	8.39M	8.3M	8.7M	8.86M	7.96M	6.37M	6.99M	6.77M	5.22M	4.93M	5.1M	5.25M	-469.35K	5.57M
Total Assets	15.28M	15.35M	15.84M	11.8M	10.73M	10.32M	13.75M	17.1M	13.72M	18.4M	24.38M	29.56M	33.69M	41.02M	46.16M	21.95M	25.33M	8.48M	6.9M	n/a	7.55M
Account Payables	1.1M	1.07M	2.03M	2.5M	2.15M	1.53M	1.32M	1.5M	1.41M	644K	1.25M	877K	920K	700.2K	1.3M	869.68K	781K	1.53M	1.31M	n/a	1.08M
Deferred Revenue	n/a	n/a	1.79M	2.4M	2.14M	2.37M	2.36M	2.65M	2.93M	2.4M	2.08M	2.34M	2.4M	3.7M	4.11M	2.8M	2.94M	3.14M	3.04M	n/a	2.95M
Short-Term Debt	477K	n/a	484K	483K	474K	n/a	447K	433K	419K	446K	383K	357K	1.26M	1.27M	1.27M	1.16M	866.97K	115K	185K	n/a	3.71M
Other Current Liabilities	3.4M	3.57M	467K	879K	560K	1.6M	2.52M	1.66M	280K	840K	1.06M	3.76M	1.46M	n/a	n/a	n/a	85.00	n/a	n/a	n/a	n/a
Total Current Liabilities	4.98M	5.13M	6.64M	8.07M	7.29M	7.17M	8.44M	7.97M	6.81M	5.96M	6.69M	6.85M	7.51M	8.2M	9.31M	7.3M	7.82M	7M	6.02M	n/a	9.09M
Long-Term Debt	1.03M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.52M	1.85M	298K	n/a	n/a	105.91K	423.1K	1.27M	1.27M	n/a	n/a
Other Long-Term Liabilities	1.32M	1.4M	1.22M	1.22M	1.22M	1.22M	1.18M	n/a	n/a	180K	-2.21M	-1.85M	343K	360K	358.4K	212.08K	163.97K	2.15M	1.82M	n/a	1.4M
Total Long-Term Liabilities	2.35M	2.56M	2.85M	3.15M	3.03M	3.1M	3.2M	2.13M	2.11M	2.58M	2.84M	1.85M	641K	360K	358.4K	317.98K	587.06K	3.41M	3.08M	n/a	1.4M
Total Liabilities	7.33M	7.68M	9.49M	11.22M	10.32M	10.27M	11.64M	10.11M	8.92M	8.54M	9.54M	8.7M	8.15M	8.56M	9.67M	7.61M	8.41M	10.41M	9.1M	n/a	10.49M
Total Debt	1.51M	1.64M	1.76M	1.88M	2M	2.1M	2.21M	2.31M	2.41M	2.85M	2.91M	2.21M	1.63M	1.27M	1.27M	1.27M	1.29M	1.38M	1.45M	n/a	3.71M
Common Stock	n/a	n/a	n/a	n/a	n/a	3K	3K	3K	2K	2K	2K	2K	2K	2.3K	2.28K	1.82K	1.82K	1.26K	1.26K	n/a	1.24K
Retained Earnings	-104.19M	-101.36M	-98.74M	-96.81M	-93.05M	-88.79M	-86.7M	-81.17M	-79.47M	-73.38M	-67.95M	-61.14M	-55.62M	-48.23M	-42.78M	-38.73M	-35.33M	-29.09M	-27.27M	n/a	-23.28M
Comprehensive Income	n/a	n/a	n/a	-0.00	n/a	0.00	-0.00	n/a	n/a	-0.00	n/a	0.00	0.00	n/a	n/a	n/a	0.00	n/a	n/a	-2.94M	-502.5K
Shareholders Equity	7.95M	7.67M	6.35M	582K	411K	46K	2.11M	6.99M	4.8M	9.86M	14.84M	20.86M	25.54M	32.47M	36.48M	14.34M	16.92M	-1.93M	-2.2M	-1.63M	-2.94M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	842.29K	846.21K	816.58K	n/a	n/a	n/a	938.71K	n/a